Ensuring safe and effective drugs: who can do what it takes?

Jefferson, Tom; Doshi, Peter; Thompson, Matthew J.; Heneghan, Carl

dc.contributor.author	Jefferson, Tom
dc.contributor.author	Doshi, Peter
dc.contributor.author	Thompson, Matthew J.
dc.contributor.author	Heneghan, Carl
dc.date.accessioned	2017-05-25T01:20:48Z
dc.date.available	2017-05-25T01:20:48Z
dc.date.issued	2011-01-11
dc.identifier.citation	Jefferson, T., Doshi, P., Thompson, M., Heneghan, C. (2011). Ensuring safe and effective drugs: who can do what it takes? BMJ, 342. DOI: 10.1136/bmj.c7258
dc.identifier.uri	http://hdl.handle.net/10713/6616
dc.description	Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, the authors discuss how to improve the reliability of systematic reviews
dc.description.uri	http://bmj.com/cgi/content/full/bmj.c7258?ijkey=VzuzLond9mt0ghC&keytype=ref	en_US
dc.language.iso	en_US	en_US
dc.publisher	BMJ Publishing Group	en_US
dc.subject	clinical study reports	en_US
dc.subject	neuraminidase inhibitors	en_US
dc.subject	research transparency	en_US
dc.subject.lcsh	F. Hoffman-La Roche & Co.	en_US
dc.subject.lcsh	Cochrane Collaboration	en_US
dc.subject.mesh	Access to Information--legislation & jurisprudence	en_US
dc.subject.mesh	Clinical Trials as Topic	en_US
dc.subject.mesh	Drug Industry	en_US
dc.subject.mesh	Oseltamivir	en_US
dc.subject.mesh	Review Literature as Topic	en_US
dc.title	Ensuring safe and effective drugs: who can do what it takes?	en_US
dc.type	Article	en_US
dc.identifier.doi	10.1136/bmj.c7258
dc.identifier.pmid	21224325
dc.description.uriname	Click here for the free full-text article on publisher's website	en_US
refterms.dateFOA	2019-02-19T18:16:05Z